| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 515.010 | 523.896 | 479.899 | 590.722 | 655.701 | 542.302 | 678.702 | 879.898 | 754.462 | 990.070 |
| Total Income - EUR | 524.441 | 532.797 | 481.612 | 643.723 | 659.017 | 542.779 | 684.952 | 897.791 | 764.237 | 1.001.158 |
| Total Expenses - EUR | 501.717 | 476.615 | 443.240 | 584.828 | 579.000 | 450.899 | 545.803 | 693.825 | 700.752 | 857.945 |
| Gross Profit/Loss - EUR | 22.724 | 56.182 | 38.372 | 58.895 | 80.016 | 91.880 | 139.150 | 203.966 | 63.485 | 143.213 |
| Net Profit/Loss - EUR | 18.546 | 49.499 | 17.487 | 52.489 | 73.457 | 86.862 | 133.166 | 195.501 | 58.929 | 117.471 |
| Employees | 23 | 27 | 22 | 22 | 22 | 15 | 13 | 15 | 14 | 15 |
Check the financial reports for the company - Oxxygene Med Plus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 619.683 | 600.351 | 592.461 | 509.246 | 522.134 | 492.994 | 731.406 | 807.515 | 785.434 | 714.084 |
| Current Assets | 28.916 | 34.865 | 75.698 | 87.896 | 90.056 | 59.433 | 40.800 | 94.280 | 113.450 | 143.985 |
| Inventories | 2.683 | 1.851 | 2.331 | 2.940 | 2.288 | 2.043 | 1.674 | 24.191 | 0 | 2.211 |
| Receivables | 23.733 | 30.963 | 36.085 | 32.636 | 33.703 | 29.739 | 24.783 | 34.191 | 38.593 | 33.445 |
| Cash | 2.500 | 2.050 | 37.282 | 52.320 | 54.065 | 27.650 | 14.343 | 35.897 | 74.857 | 108.329 |
| Shareholders Funds | 282.549 | 282.582 | 295.287 | 326.597 | 393.729 | 418.711 | 509.885 | 563.956 | 626.592 | 582.842 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 366.050 | 352.634 | 372.948 | 278.140 | 223.765 | 137.668 | 264.688 | 250.212 | 168.140 | 182.669 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 87.744 | 104.297 | 92.635 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Oxxygene Med Plus Srl